Page last updated: 2024-08-23

cefoperazone and kanamycin a

cefoperazone has been researched along with kanamycin a in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19906 (50.00)18.7374
1990's0 (0.00)18.2507
2000's4 (33.33)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayala, JA; Casellas, JM; Di Conza, J; Ghiglione, B; Gutkind, G; Power, P; Radice, M; Rodríguez, MM1
Kwon, DH; Lu, CD1
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hernández, NI; Nevárez, M; Ramírez-Ronda, CH; Rodríguez, JR1
Klastersky, J; Lagast, H; Van Laethem, Y1
Meyer, RD; Pasiecznik, K1
Accornero, L; Bacigalupo, A; Carella, AM; Congiu, AM; Costa, G; Occhini, D; Santini, G; Sbaffi, A; Sciutto, C; Van Lint, MT1
Husson, M; Klastersky, J; Van Laethem, Y1
Chang, ST; Chung, ES; Whang, CW1
Ishitobi, J; Kamiya, A; Oie, S; Sawa, A; Tomita, M1

Reviews

1 review(s) available for cefoperazone and kanamycin a

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

11 other study(ies) available for cefoperazone and kanamycin a

ArticleYear
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Catalysis; Citrobacter freundii; Conjugation, Genetic; DNA, Bacterial; DNA, Recombinant; Enterobacteriaceae; Genes, Bacterial; Humans; Hydrolysis; Isoelectric Focusing; Kinetics; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Conformation; Protein Sorting Signals; Sequence Analysis, DNA

2007
Polyamine effects on antibiotic susceptibility in bacteria.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
    Boletin de la Asociacion Medica de Puerto Rico, 1985, Volume: 77, Issue:6

    Topics: Amikacin; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Drug Synergism; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa

1985
Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 1983, Volume: 23, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Blood Bactericidal Activity; Cefoperazone; Ceftazidime; Cephalosporins; Drug Synergism; Humans; Kanamycin; Klebsiella pneumoniae; Pseudomonas aeruginosa

1983
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Diagnostic microbiology and infectious disease, 1983, Volume: 1, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Synergism; Imipenem; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins

1983
Cefoperazone versus cefotaxime, plus amikacin or sisomicin, in fever and infection in hematologic granulocytopenic patients.
    Tumori, 1984, Apr-30, Volume: 70, Issue:2

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anemia, Aplastic; Cefoperazone; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Immunosuppression Therapy; Infections; Kanamycin; Leukemia; Male; Middle Aged; Random Allocation; Sisomicin

1984
Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Bacteria; Bacteriological Techniques; Cefoperazone; Drug Therapy, Combination; Escherichia coli; Humans; Kanamycin; Klebsiella pneumoniae; Pseudomonas aeruginosa; Serratia marcescens; Time Factors

1984
Comparative study of cefoperazone and amikacin.
    Clinical therapeutics, 1984, Volume: 7, Issue:1

    Topics: Amikacin; Bacteria; Cefoperazone; Humans; Kanamycin; Microbial Sensitivity Tests; Surgical Wound Infection

1984
In vitro bactericidal activity of antimicrobial agents against enterohaemorrhagic Escherichia coli.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:5

    Topics: Anti-Bacterial Agents; Cefoperazone; Electrophoresis, Gel, Pulsed-Field; Escherichia coli O157; Fosfomycin; Kanamycin; Microbial Sensitivity Tests; Norfloxacin

2004